Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study

Background: An extended interval between the two primary doses may reduce the risk of myocarditis/pericarditis after COVID-19 mRNA vaccination. Taiwan has implemented a two-dose regimen with a 12-week interval for adolescents. Here we present nationwide data of myocarditis/pericarditis following COV...

Full description

Bibliographic Details
Main Authors: Wei-Ju Su, Yu-Lun Liu, Chia-Hsuin Chang, Yen-Ching Lin, Wei-I Huang, Li-Chiu Wu, Shu-Fong Chen, Yu-Sheng Lin, Yee-Lin Hsieh, Chiao-An Yang, Chiu-Hsiang Lin, Kim-Wei Arnold Chan, Ping-Ing Lee, Jen-Hsiang Chuang, Chin-Hui Yang
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
COVID-19
Vaccination
Myocarditis
Pericarditis
Population-based study
Online Access:http://www.sciencedirect.com/science/article/pii/S168411822300035X

Internet

http://www.sciencedirect.com/science/article/pii/S168411822300035X

Similar Items